GALECTIN THERAPEUTICS INC

GALT · Nasdaq · SIC 2834: Pharmaceutical Preparations
341
SEC Filings

Business Summary

PART I Overview We are a clinical stage biopharmaceutical company engaged in drug research and development to create new therapies for fibrotic disease, cancer and selected other diseases. Our drug candidates are based on our method of targeting galectin proteins, which are key mediators of biologic and pathologic functions. We use naturally occurring, readily-available plant products as starting material in manufacturing processes to create proprietary, patented complex carbohydrates with speci...

Next Earnings

Q2 FY2026 — expected 2026-09-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionGALTdiscussed_in_filing Cybersecurity
topic_mentionGALTdiscussed_in_filing Trusted Computing
topic_mentionGALTdiscussed_in_filing Blockchain & Crypto
topic_mentionGALTdiscussed_in_filing Regulation
topic_mentionGALTdiscussed_in_filing Healthcare & Bio
topic_mentionGALTdiscussed_in_filing Sovereign & Government
topic_mentionGALTdiscussed_in_filing Cybersecurity
topic_mentionGALTdiscussed_in_filing Trusted Computing
topic_mentionGALTdiscussed_in_filing Blockchain & Crypto
topic_mentionGALTdiscussed_in_filing Regulation
topic_mentionGALTdiscussed_in_filing Healthcare & Bio
topic_mentionGALTdiscussed_in_filing Sovereign & Government
topic_mentionGALTdiscussed_in_filing Cybersecurity
topic_mentionGALTdiscussed_in_filing Trusted Computing
topic_mentionGALTdiscussed_in_filing Blockchain & Crypto
topic_mentionGALTdiscussed_in_filing Regulation
topic_mentionGALTdiscussed_in_filing Healthcare & Bio
topic_mentionGALTdiscussed_in_filing Sovereign & Government
topic_mentionGALTdiscussed_in_filing Cybersecurity
topic_mentionGALTdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001140361-26-012155EDGAR63K words
2025-03-312024-12-310001140361-25-011169EDGAR—
2024-03-292023-12-310001140361-24-016452EDGAR—
2023-03-302022-12-310001140361-23-014658EDGAR—
2022-03-312021-12-310001140361-22-012058EDGAR—
2021-03-312020-12-310001193125-21-101402EDGAR—
2020-03-162019-12-310001193125-20-073907EDGAR—
2019-03-062018-12-310001193125-19-064705EDGAR—
2018-03-292017-12-310001193125-18-100592EDGAR—
2017-03-282016-12-310001193125-17-098753EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001140361-25-042116EDGAR24K words
2025-08-142025-06-300001140361-25-031039EDGAR—
2025-05-152025-03-310001140361-25-019149EDGAR—
2024-11-142024-09-300001140361-24-046726EDGAR—
2024-08-132024-06-300001140361-24-036937EDGAR—
2024-05-152024-03-310001140361-24-026105EDGAR—
2023-11-132023-09-300001140361-23-052729EDGAR—
2023-08-142023-06-300001140361-23-039411EDGAR—
2023-05-152023-03-310001140361-23-024499EDGAR—
2022-11-142022-09-300001140361-22-041167EDGAR—
2022-08-152022-06-300001140361-22-029555EDGAR—
2022-05-162022-03-310001140361-22-019248EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001140361-26-012158EDGAR2K words
2026-03-170001140361-26-009735EDGAR—
2026-01-210001140361-26-001866EDGAR—
2026-01-120001140361-26-000994EDGAR—
2025-12-190001140361-25-046115EDGAR—
2025-12-080001140361-25-044711EDGAR—
2025-12-030001140361-25-044148EDGAR—
2025-11-140001140361-25-042118EDGAR—
2025-11-100001140361-25-041275EDGAR—
2025-09-080001140361-25-034242EDGAR—

341 total filings indexed. 309 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001133416
TickerGALT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 26f0370850c5a3f1e5abd4822bf0b2c3ffdc60f66bfd19be813cb4e9a20dfe63
parent: 7cb234d9db5adbeb97fdd6fc9d4264116fd7572ff6356b161db297b676fc1ee3
content hash: 7ec90b66f6bb251f789c42cd16e0893bc972ad9b1392e22a7b97fbbe63547262
signed: 2026-04-13T04:45:11.672Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf